SF3A3 and cancer: Hence, it has been shown that ZFP207 interacts with the splicing components U2AF65 and SF3a3, and transcriptomic analysis revealed splicing defects after depletion of ZFP207 in cancer cells, although such splicing events were not thoroughly characterized (Wan et al, 2015).